制药公司和保险公司将领导人工智能变革患者护理，实现更快诊断和个性化药物
英文摘要
A report from Infosalus indicates that pharmaceutical and insurance companies are taking leadership in artificial intelligence, which is expected to transform patient experience. AI will enable faster diagnoses, personalized medications, and insurance policies tailored to real individual risk. The technology promises to streamline care delivery and enhance clinical accuracy for end-users. This shift highlights the growing integration of AI in healthcare and financial services to improve outcomes.
中文摘要
据Infosalus报道，制药公司和保险公司正在人工智能领域占据领先地位，这将改变患者体验。AI将实现更快的诊断、个性化药物和根据实际风险量身定制的保险单。该技术有望优化医疗服务流程，提高对终端用户的临床精确度。这一转变凸显了AI在医疗保健和金融服务中日益深入的融合，以改善结果。
关键要点
Pharmaceutical and insurance companies are leading the adoption of AI in their sectors.
制药和保险公司正在各自领域引领人工智能的应用。
AI will enable faster diagnoses, personalized drugs, and risk-adapted insurance policies.
人工智能将实现更快的诊断、个性化药物和根据风险定制的保险单。
The integration of AI aims to accelerate care delivery and improve clinical precision for patients.
人工智能的整合旨在加快医疗服务提供速度并提高对患者的临床精确度。